Zdrowie i gospodarka · 17/07/2015
FDA Releases Draft Guidance on Testicular Toxicity Evaluation During Drug Development
The FDA has released a draft guidance to help pharmaceutical companies identify potential testicular toxicity in their drugs and monitor adverse effects early in clinical trials.